Developer docs
API playgroundTry for free, no card

Search company profiles

ECOGENE-21

Full company profile

uuid002qvea

Namestring
ECOGENE-21
Websiteurl
ecogene21.org
Company typeenum
Private
Founded yearint
2008
Descriptiontext

ECOGENE-21 is a Canadian non-profit clinical research organization headquartered in Chicoutimi, Quebec, founded in 2008. The company provides clinical research and therapeutics development services, operating in the contract research organization (CRO) segment that supports pharmaceutical, biotechnology, and academic clients in advancing drug development and clinical programs.

The organization employs between 11 and 50 staff, indicating a small-to-mid-sized operational footprint typical of specialized regional CROs. Its base in Chicoutimi positions it within the Saguenay academic and clinical research ecosystem. However, the available source material is severely limited — the company's website was inaccessible at the time of data collection (displaying only a verification/loading page), and no details on specific service offerings, technology platforms, clinical trial portfolio, therapeutic area focus, pricing models, or partnerships could be confirmed.

ECOGENE-21's revenue model is unverified but, consistent with its non-profit status, likely involves a combination of government research grants, contract research revenue from industry clients, and possibly academic collaborations. No financials, management team details, certifications, or strategic transaction data were available to assess commercial traction, governance structure, or pipeline of active studies. This data gap materially limits any investment-grade assessment of the organization.

Short descriptiontext

ECOGENE-21 is a Canadian non-profit clinical research organization based in Chicoutimi, Quebec, providing clinical research and therapeutics development services to pharmaceutical, biotech, and academic clients. Founded in 2008, it operates with 11-50 staff.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSacré-coeur-saguenay, Canada
HQ citystring
Sacré-coeur-saguenay
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical research services, therapeutics development, pharmacogenomics research, clinical trial support, medical research
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services
Social media profiles2 records
Cost components4 values
Personnel, Operations, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ECOGENE-21 is a non-profit clinical research organization that provides clinical research and therapeutics development services. It supports studies and translational research programs for the medical research community, leveraging a small, specialized team based in Chicoutimi, Canada.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product information available. The website currently displays a verification loading page with no accessible content.

No data
Peers10 records
TypeDirect peer
Description

Early-phase clinical research CRO focused on translational and clinical pharmacology services. Comparable to ECOGENE-21's clinical research and therapeutics development positioning.

TypeBroad incumbent
Description

Largest global CRO with full-spectrum clinical research and therapeutic development services. Comparable as a clinical research services provider, though operating as a broad incumbent across many therapeutic areas.

3Centre de recherche du CHUM (CRCHUM)
TypeDirect peer
Description

Quebec-based university hospital research center running clinical and translational research programs. Comparable as a Quebec research organization supporting clinical research and therapeutics studies.

TypeBroad incumbent
Description

Global CRO offering preclinical and clinical research services across the drug development spectrum. Comparable as an established CRO serving therapeutics developers, though operating at much greater scale and scope.

TypeDirect peer
Description

Independent CRO specializing in early-stage clinical trials and neuroscience research. Comparable as a specialized clinical research organization offering therapeutics-related trial services.

6Institut de recherches cliniques de Montréal (IRCM)
TypeDirect peer
Description

Quebec-based non-profit clinical research institute focused on biomedical and therapeutic research. Comparable as a Quebec non-profit research organization conducting clinical and therapeutics development work.

TypeDirect peer
Description

Global CRO/CDMO offering laboratory, clinical, and bioanalytical services for drug development. Comparable as a CRO supporting therapeutics development with a similar research-services business model.

TypeDirect peer
Description

Canadian-headquartered CRO offering preclinical and clinical research services to biopharma. Comparable as a Canadian clinical research organization serving drug development clients, though significantly larger in scale.

TypeDirect peer
Description

Mid-sized global CRO providing Phase I–IV clinical research and bioanalytical services. Directly comparable as a CRO focused on clinical research delivery for therapeutic sponsors.

TypeDirect peer
Description

Canadian non-profit research institute focused on translational and clinical cancer research. Comparable as a Canadian non-profit research organization conducting clinical and therapeutics development work.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ECOGENE-21

Clinical Research Servicesecogene21.org

ECOGENE-21 is a Canadian non-profit clinical research organization based in Chicoutimi, Quebec, providing clinical research and therapeutics development services to pharmaceutical, biotech, and academic clients. Founded in 2008, it operates with 11-50 staff.

What ECOGENE-21 does

ECOGENE-21 is a Canadian non-profit clinical research organization headquartered in Chicoutimi, Quebec, founded in 2008. The company provides clinical research and therapeutics development services, operating in the contract research organization (CRO) segment that supports pharmaceutical, biotechnology, and academic clients in advancing drug development and clinical programs.

The organization employs between 11 and 50 staff, indicating a small-to-mid-sized operational footprint typical of specialized regional CROs. Its base in Chicoutimi positions it within the Saguenay academic and clinical research ecosystem. However, the available source material is severely limited — the company's website was inaccessible at the time of data collection (displaying only a verification/loading page), and no details on specific service offerings, technology platforms, clinical trial portfolio, therapeutic area focus, pricing models, or partnerships could be confirmed.

ECOGENE-21's revenue model is unverified but, consistent with its non-profit status, likely involves a combination of government research grants, contract research revenue from industry clients, and possibly academic collaborations. No financials, management team details, certifications, or strategic transaction data were available to assess commercial traction, governance structure, or pipeline of active studies. This data gap materially limits any investment-grade assessment of the organization.

ECOGENE-21 firmographics

Firmographics
Name
ECOGENE-21
Website
https://ecogene21.org
Company type
Private
Founded year
2008
Headcount range
11–50 employees
Short description
ECOGENE-21 is a Canadian non-profit clinical research organization based in Chicoutimi, Quebec, providing clinical research and therapeutics development services to pharmaceutical, biotech, and academic clients. Founded in 2008, it operates with 11-50 staff.
Ownership category
akta.pro rank

Where ECOGENE-21 is headquartered

Location

Headquarters

HQ city
Sacré-coeur-saguenay
HQ country
Canada
HQ region
North America

Markets served

ECOGENE-21 business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure

ECOGENE-21 product offering

Product offering

Core offering

ECOGENE-21 is a non-profit clinical research organization that provides clinical research and therapeutics development services. It supports studies and translational research programs for the medical research community, leveraging a small, specialized team based in Chicoutimi, Canada.

Product overview

No product information available. The website currently displays a verification loading page with no accessible content.

Differentiator

Problem solved

Functional benefit

Companies that use ECOGENE-21

Customer profile

Ideal customer profiles1 record

ECOGENE-21 technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

ECOGENE-21 competitors and assessment

Company assessment

Direct peers

  • Celerion: Early-phase clinical research CRO focused on translational and clinical pharmacology services. Comparable to ECOGENE-21's clinical research and therapeutics development positioning.
  • Centre de recherche du CHUM (CRCHUM): Quebec-based university hospital research center running clinical and translational research programs. Comparable as a Quebec research organization supporting clinical research and therapeutics studies.
  • Biotrial: Independent CRO specializing in early-stage clinical trials and neuroscience research. Comparable as a specialized clinical research organization offering therapeutics-related trial services.
  • Institut de recherches cliniques de Montréal (IRCM): Quebec-based non-profit clinical research institute focused on biomedical and therapeutic research. Comparable as a Quebec non-profit research organization conducting clinical and therapeutics development work.
  • Pharmaron: Global CRO/CDMO offering laboratory, clinical, and bioanalytical services for drug development. Comparable as a CRO supporting therapeutics development with a similar research-services business model.
  • Altasciences: Canadian-headquartered CRO offering preclinical and clinical research services to biopharma. Comparable as a Canadian clinical research organization serving drug development clients, though significantly larger in scale.
  • Worldwide Clinical Trials: Mid-sized global CRO providing Phase I–IV clinical research and bioanalytical services. Directly comparable as a CRO focused on clinical research delivery for therapeutic sponsors.
  • Ontario Institute for Cancer Research (OICR): Canadian non-profit research institute focused on translational and clinical cancer research. Comparable as a Canadian non-profit research organization conducting clinical and therapeutics development work.

Broad incumbents

  • IQVIA: Largest global CRO with full-spectrum clinical research and therapeutic development services. Comparable as a clinical research services provider, though operating as a broad incumbent across many therapeutic areas.
  • Charles River Laboratories: Global CRO offering preclinical and clinical research services across the drug development spectrum. Comparable as an established CRO serving therapeutics developers, though operating at much greater scale and scope.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

ECOGENE-21 social profiles

Digital presence

ECOGENE-21 financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ECOGENE-21 leadership team

Management profile

Number of profiles

ECOGENE-21 funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ECOGENE-21 M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ECOGENE-21

What does ECOGENE-21 do?

ECOGENE-21 is a non-profit clinical research organization that provides clinical research and therapeutics development services. It supports studies and translational research programs for the medical research community, leveraging a small, specialized team based in Chicoutimi, Canada.

When was ECOGENE-21 founded?

ECOGENE-21 was founded in 2008. It employs 11 to 50 people.

Where is ECOGENE-21 based?

ECOGENE-21 is headquartered in Sacré-coeur-saguenay, Canada, in the North America region.

Who are ECOGENE-21's main competitors?

Direct peers on record are Celerion, Centre de recherche du CHUM (CRCHUM), Biotrial, Institut de recherches cliniques de Montréal (IRCM), Pharmaron, Altasciences, Worldwide Clinical Trials and Ontario Institute for Cancer Research (OICR). Broad incumbents are IQVIA and Charles River Laboratories.

Does ECOGENE-21 have an API?

No public API is recorded for ECOGENE-21.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales